Takeda Pharmaceuticals

NCDA partner

About Takeda

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries. For more information, visit takeda.com

Takeda's work on complex and rare diseases

Complex and rare diseases are hard to diagnose, treat and manage. These conditions present significant challenges in terms of the levels of capacity, and resources needed to prevent, educate and raise awareness, and the specialised clinical skills needed to screen, diagnose and treat patients. Complex and rare diseases often have greater affordability barriers. They may require highly innovative medicines, often without alternatives, and the treatment can be lifelong.

Increasing access to innovative medicines for these diseases is challenging and needs collective action. It must be approached in a sustainable and targeted way, to strengthen and transform healthcare systems, at every stage of the patient journey - from awareness and diagnosis, to treatment and ongoing patient support.

As a global biopharmaceutical leader, Takeda is committed to translating science into highly-innovative medicines for complex and rare diseases to make a difference to people’s lives. We are also committed to develop and deliver innovative vaccines that tackle tough problems in public health.